Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $3,989 - $4,436
-17 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $2,571 - $3,155
13 Added 325.0%
17 $5,000
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $728 - $966
4 New
4 $1,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Western Asset Management Company, LLC Portfolio

Follow Western Asset Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Asset Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Asset Management Company, LLC with notifications on news.